Vincent et al. report the effect of MEK inhibitor trametinib in two children with syndromic KRAS-related multiple non-ossifying fibromas (NOFs). This treatment in vitro reduces KRAS pathway ...

Medical news, education and information for physicians and health care professionals, presented by specialty and topic. From Healio and the Wyanoke Group.